Baidu
map

SLEEP:睡眠障碍与 TBI 患者痴呆风险增加有关

2021-06-10 Viho MedSci原创

近日,一项发表在SLEEP上的,针对 700,000 多名脑外伤 (TBI) 患者进行的研究的初步结果表明,睡眠障碍患者患痴呆症的风险增加。

近日,一项发表在SLEEP上的,针 700,000 多名脑外伤 (TBI) 患者进行的研究的初步结果表明,睡眠障碍患者患痴呆症的风险增加。该研究将于 6 13 日在Virtual SLEEP 2021期间以口头报告形式呈现。SLEEP 是美国睡眠医学会和睡眠研究协会的合资企业——美国专业睡眠协会的年会。

该项回顾性研究的患者在 2003 5 月至 2013 4 月期间被送往急诊科或急诊医院并被诊断 TBI 时没有痴呆。总样本包括所有患有严重性。本研究共包括712,708名各种严重程度的TBI患者。中位年龄为 44 岁,59% 是男性。

 主要暴露是睡眠障碍,主要结果是痴呆症,两者都由国际疾病分类第十次修订版诊断来定义。睡眠障碍与痴呆症的关系通过多变量Cox比例危险模型进行分析。

 52个月的中位随访中(四分位数范围,19-86个月),32,834人(4.6%)患上了痴呆症。在控制了年龄、性别、收入水平、受伤严重程度和已知的合并症风险后,诊断出的睡眠障碍是发生痴呆症的一个重要预测因素:危险比(HR),1.250[95% CI1.146-1.363]。当结果按性别分层时,睡眠障碍与痴呆症的关系在男性中仍然显著:HR 1.255 [95% CI, 1.112-1.415],在女性患者中仍然显著。HR 1.234 [95% CI, 1.088-1.400]。对阿尔茨海默病病例定义的敏感性分析和使用FineGray竞争风险模型证实了睡眠障碍和痴呆症在两性中的关联。

 结果表明,在超过四年的中位随访期间,被诊断出睡眠障碍的 TBI 患者患痴呆症的可能性要高 25%按性别分层时的结果相似:患有睡眠障碍的男性 TBI 患者患痴呆症的风险增加 25.5%,女性 TBI 患者患痴呆症的风险增加 23.4%

 该研究是第一个报告睡眠障碍和其他因素分别对男性和女性 TBI 患者造成的风险的研究。

 我们的研究的新颖之处在于它证实了睡眠障碍与男性和女性患者发生痴呆症的关联,独立于其他已知的痴呆症风险,主要作者和主要研究员、风筝研究所附属科学家 Tatyana Mollayeva 博士说,同时她也指出,与两性痴呆发病率的密切联系表明,需要对 TBI 患者进行更有针对性的睡眠障碍风险意识,

原始出处:794 Contribution of sleep disorders to dementia incidence following traumatic brain injury: A decade-long retrospective cohort study. https://doi.org/10.1093/sleep/zsab072.791

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2022-02-03 1dea0131m20(暂无匿称)

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2022-01-12 hxj0117
  3. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-11 ms5000001756152328

    很好👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-11 1483f8cem53(暂无昵称)

    赚积分

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 ms4000001408306525

    学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 ms3000001619278799

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 天天夜夜

    厉害啊

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1189986, encodeId=569a11899867a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66c11710318, createdName=1dea0131m20(暂无匿称), createdTime=Thu Feb 03 19:11:44 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887284, encodeId=288e188e2841a, content=<a href='/topic/show?id=33971e181b8' target=_blank style='color:#2F92EE;'>#TBI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17181, encryptionId=33971e181b8, topicName=TBI)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Wed Jan 12 11:06:23 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972870, encodeId=35e29e287086, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9665485729, createdName=ms5000001756152328, createdTime=Fri Jun 11 15:27:15 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316781, encodeId=4dfd1316e8121, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345045, encodeId=fa7a1345045c0, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kbRUeosenzlejlNGWXdWjSYhBKL1QYGQwfehJOkMXHiavh5wl7pKeju5Kcxdvr50ic6FWML3x6NMCxhG1bOaVjyA/132, createdBy=20872500216, createdName=ms4657536712156177, createdTime=Fri Jun 11 15:06:23 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972707, encodeId=31b39e270722, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Fri Jun 11 00:03:57 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972401, encodeId=a3589e240100, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/a3241b5f9a3a4daf8ae07d6fa03675a7/5300ece71ed8431789ade13ff3913d93.jpg, createdBy=3d6f5518160, createdName=ms4000001408306525, createdTime=Thu Jun 10 09:29:51 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972383, encodeId=35359e2383eb, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/faaf0b77499240d0ac8851c324db58c1/69e58b875d4749349a094a0254a3d8c4.jpg, createdBy=643c5445417, createdName=ms3000001619278799, createdTime=Thu Jun 10 08:42:08 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972351, encodeId=5dc59e235128, content=厉害啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210610/6fffdd349cc740d4a104c66bb4eecbbc/b96c236856c545cf9f9e1bed6e2bf9be.jpg, createdBy=c9885510159, createdName=天天夜夜, createdTime=Thu Jun 10 04:47:41 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048801, encodeId=753310488018c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 10 03:06:23 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 junJUN

    老年人痴呆何药可用??

    0

相关资讯

JAMA Netw Open:睡眠障碍或是儿童和青少年抑郁症的潜在风险!

据世界卫生组织发布的数据显示,全球约有3.22亿人患抑郁症,占全球人口的4.4%,也就是平均每23个人里就有一名抑郁症患者。

BMC Gastroenterology:改善睡眠障碍对功能性消化不良患者症状的改善具有重要意义

众所周知,许多患者具有功能性胃肠(GI)紊乱的患者都存在睡眠障碍,功能性消化不良(FD)也常与睡眠障碍相伴发生。

EClinicalMedicine:全球超17万人研究显示,碳酸软饮料和快餐严重影响青少年睡眠质量

睡眠对青少年身心发育,情绪及学习生活影响巨大。诸多研究显示,睡眠质量是影响青少年心理健康和认知发展的重要因素。睡眠不足和睡眠质量差不仅会影响青少年的情绪(如抑郁和焦虑)和行为生活(如攻击和欺凌)

BMJ Open:长期使用睡眠药物或不能改善睡眠质量

据统计,我国有超过3亿人存在睡眠障碍,成年人失眠发生率达38.2%,六成以上的90后觉得睡眠不足,失眠成为了现代人的“新”流行病。

Stroke:卒中或短暂性脑缺血发作后睡眠障碍的患病率

随着时间的推移,卒中或TIA后的睡眠障碍非常常见。该研究的结果表明卒中或TIA后早期筛查和治疗睡眠障碍的重要性。

拓展阅读

Neurology:预测患有轻度认知障碍或轻度痴呆的淀粉样蛋白阳性患者的认知能力下降

本研究构建了 MCI 和轻度痴呆的模型,这些模型可以预测 MMSE 随时间的变化。

Alzheimers Dement :MIND 饮食、大脑转录组改变和痴呆

本研究为健康饮食模式如何影响认知功能的分子机制提供了新的视角。MIND饮食相关的转录组特征可能成为未来痴呆预防和治疗研究的重要靶点。

JAMA:阿尔茨海默病血液生物标志物的变化以及与发生性全因痴呆的关联

AD特异性生物标志物与痴呆症的关联始于中年,而AD、神经元损伤和星形胶质细胞增生生物标志物的晚年测量都与痴呆症有关。

JAMA:在初级保健和二级保健中检测阿尔茨海默病的血液生物标志物

在初级和二级保健中使用预定义的临界值,APS2 和单独使用 p-tau217 的百分比对于识别有认知症状的个体 AD 具有很高的诊断准确性

JAMA Neuro:注意了,原因不明的瘙痒可能与额颞叶痴呆有关!

在患有 IUO 的个体中,与 AD 相比,FTLD-SD 的比例过高。

Neurology:多基因风险评分、APOE 基因型与痴呆症风险相关性分析

IC 与较高的痴呆症风险相关,尤其是那些合并有痴呆症易感基因的人。

Baidu
map
Baidu
map
Baidu
map